Unicheer Biotech Group Inc entered the industry of in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 4461100, which describes it as a . For further clarification, the SIC classifies this business under the code 5047 and described it as a . The business provides service to the B2B market.
To acquire more information, please contact Michael Liminger, Vice President by calling (909) 390-5588 during business hours. You can also write to the business’ Single Location at 1801 Excise Avenue, Ontario, California CA 91761. You can also visit the company’s website at yaeyamachlorella.cn. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Unicheer Biotech Group Inc |
Representative: | Michael Liminger, Vice President |
Place of Business: | 1801 Excise Avenue, Ontario, CA 91761 |
Contact Number: | (909) 390-5588 |
Website: | yaeyamachlorella.cn |
Type of Service: | |
SIC Number: | 5047 |
NAICS Number: | 4461100 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2010 |
Income/Year: | $1.000.000 to $2.499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Unicheer Biotech Group Inc is a company operating from San Bernardino, California providing professional and relevant B2B variables. It was founded in 2010 and registered with the SIC code 5047 as , and with the NAICS code 4461100 as .
With a current employee count of 1 to 4, Unicheer Biotech Group Inc has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Michael Liminger, Vice President at (909) 390-5588 for related queries, or to locate its Single Location using the coordinates 34.04175,-117.57741.
The Single Location can also be found at the street address 1801 Excise Avenue in Ontario, California 91761 and can be engaged online through the company website at yaeyamachlorella.cn, the company Twitter , and Facebook page .